“ab fubinaca”的搜索结果

14 个项目

每页

设置降序顺序
  1. Taranabant ((1R,2R)stereoisomer)

    Catalog No. A21705
    Quick View
    CB1 receptor inverse agonist
    Taranabant (1R,2R)stereoisomer is the R-enantiomer of Taranabant. Taranabant is a highly potent and selective cannabinoid 1 (CB1) receptor inverse agonist. 了解更多
  2. Taranabant racemate

    Catalog No. A21699
    Quick View
    CB1 antagonist/inverse agonist
    Taranabant racemate is an antagonist and/or inverse agonist of the Cannabinoid-1 (CB1) receptor extracted from patent WO 2004048317 A1. 了解更多
  3. (±)-Ibipinabant

    Catalog No. A21439
    Quick View
    CB-1 receptor antagonist
    (±)-Ibipinabant ((±)-SLV319) is the racemate of SLV319. (±)-Ibipinabant ((±)-SLV319) is a potent and selective cannabinoid-1 (CB-1) receptor antagonist with an IC50 of 22 nM. 了解更多
  4. Taranabant

    Catalog No. A11578
    Quick View
    CB1 receptor inverse agonist
    Taranabant is a highly potent and selective cannabinoid 1 (CB1) receptor inverse agonist that inhibits the binding and functional activity of various agonists, with a binding Ki of 0.13 nM for the human CB1R in vitro. 了解更多
  5. CB2R-IN-1

    Catalog No. A12306
    Quick View
    cannabinoid CB2 receptor inverse agonist
    CB2R-IN-1 is a potent cannabinoid CB2 receptor inverse agonist with a Ki of 0.9 nM. 了解更多
  6. CB1 antagonist 2

    Catalog No. A18810
    Quick View
    CB1 antagonist
    CB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3, inhibits CB1 in vivo with an IC50 of 25.5 nM. 了解更多
  7. VCE-004.8

    Catalog No. A18549
    Quick View
    PPARγ and CB2 receptor dual agonist
    VCE-004.8, a semi-synthetic multitarget cannabinoquinoid, is a specific PPARγ and CB2 receptor dual agonist with potent anti-inflammatory activity. 了解更多
  8. Rimonabant hydrochloride

    Catalog No. A11548
    Quick View
    CB1 receptor inverse 激动剂
    Rimonabant hydrochloride是CB1受体反向激动剂。 了解更多
  9. Otenabant

    Catalog No. A15200
    Quick View
    CB1 receptor 拮抗剂
    Otenabant是最近发现的选择性,高亲和力,竞争性CB1受体拮抗剂,Ki为0.7 nM。 了解更多
  10. Tedalinab

    Catalog No. A14189
    Quick View
    CB2 receptor 激动剂
    Tedalinab (GRC-10693)是开发用于治疗骨关节炎和神经性疼痛的药物,它可作为有效的选择性大麻素CB2受体激动剂。与相关的CB1受体相比,它对CB2的选择性为4700x,具有很高的口服生物利用度,并在早期临床试验中显示出令人鼓舞的安全性结果以及有效的镇痛和抗炎作用。 了解更多
  11. AM 2201

    Catalog No. A14174
    Cannabinoid 抑制剂
    AM2201是有效的合成大麻素(CB),对于CB1和CB2受体的Ki值分别为1.0和2.6 nM。 了解更多
  12. Rimonabant (SR141716)

    Catalog No. A11547
    Quick View
    Rimonabant是CB1的选择性拮抗剂,在hCB1转染的HEK 293膜中的IC50为13.6 nM,EC50为17.3 nM。 了解更多
  13. CP 945598 HCl (Otenabant HCl)

    Catalog No. A11942
    Quick View
    CB1 拮抗剂
    CP 945598 HCl (Otenabant HCl)是一种有效且高度选择性的CB1拮抗剂。 了解更多
  14. WIN 55,212-2 mesylate

    Catalog No. A11932
    Quick View
    CB receptor 激动剂
    WIN 55,212-2 mesylate是一种有效的cannabinoid receptor激动剂,在神经性疼痛的大鼠模型中具有有效的镇痛作用。它通过受体介导的信号激活p42和p44 MAP激酶。 了解更多

14 个项目

每页

设置降序顺序
Rewards